Profile data is unavailable for this security.
About the company
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
- Revenue in USD (TTM)1.06bn
- Net income in USD90.95m
- Incorporated2004
- Employees4.20k
- LocationPenumbra IncOne Penumbra PlaceALAMEDA 94502United StatesUSA
- Phone+1 (510) 748-3200
- Fax+1 (302) 531-3150
- Websitehttps://www.penumbrainc.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merit Medical Systems Inc | 1.26bn | 94.41m | 4.36bn | 6.95k | 46.41 | 3.61 | 23.65 | 3.47 | 1.62 | 1.62 | 21.55 | 20.78 | 0.6304 | 2.36 | 7.34 | 180,916.00 | 4.73 | 2.45 | 5.30 | 2.77 | 46.44 | 44.50 | 7.51 | 3.91 | 3.95 | 9.89 | 0.4064 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Lantheus Holdings Inc | 1.30bn | 326.66m | 4.61bn | 834.00 | 14.49 | 5.65 | 11.92 | 3.56 | 4.64 | 4.64 | 18.59 | 11.91 | 0.8723 | 9.46 | 5.21 | 1,554,471.00 | 21.98 | 6.69 | 25.75 | 7.73 | 63.71 | 53.90 | 25.20 | 9.02 | 5.45 | 1,235.43 | 0.4081 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Haemonetics Corporation | 1.27bn | 126.57m | 4.65bn | 3.03k | 37.02 | 4.93 | 21.12 | 3.66 | 2.47 | 2.47 | 24.80 | 18.57 | 0.6229 | 2.11 | 6.47 | 418,649.00 | 6.21 | 4.74 | 7.05 | 5.89 | 53.48 | 49.87 | 9.97 | 7.41 | 1.76 | 26.49 | 0.48 | 0.00 | 17.67 | 5.27 | 166.05 | 9.48 | 8.06 | -- |
| Glaukos Corp | 314.71m | -134.66m | 4.86bn | 907.00 | -- | 10.34 | -- | 15.44 | -2.78 | -2.78 | 6.50 | 9.40 | 0.324 | 1.89 | 8.29 | 346,980.20 | -13.86 | -8.73 | -14.99 | -9.35 | 75.99 | 74.77 | -42.79 | -28.69 | 4.78 | -27.68 | 0.4335 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Novanta Inc | 881.66m | 72.88m | 5.74bn | 2.90k | 79.12 | 8.51 | 48.07 | 6.51 | 2.02 | 2.02 | 24.47 | 18.80 | 0.7147 | 3.04 | 6.36 | 304,021.40 | 5.91 | 5.46 | 6.74 | 6.34 | 45.36 | 43.24 | 8.27 | 7.71 | 1.91 | 4.83 | 0.3477 | 0.00 | 2.41 | 7.49 | -1.58 | 8.21 | 4.19 | -- |
| DENTSPLY SIRONA Inc | 3.97bn | -132.00m | 6.37bn | 15.00k | -- | 1.93 | 30.20 | 1.61 | -0.6217 | -0.6217 | 18.67 | 15.89 | 0.5282 | 3.00 | 5.98 | 264,333.30 | -1.76 | -1.14 | -2.13 | -1.32 | 52.71 | 53.65 | -3.33 | -2.51 | 0.9467 | 3.63 | 0.3914 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| Globus Medical Inc | 1.57bn | 122.87m | 6.85bn | 5.00k | 43.43 | 1.73 | 25.52 | 4.37 | 1.17 | 1.17 | 13.72 | 29.32 | 0.438 | 0.9557 | 4.38 | 313,695.20 | 3.43 | 6.90 | 3.72 | 7.45 | 65.05 | 71.73 | 7.83 | 14.05 | 2.72 | -- | 0.0947 | 0.00 | 53.34 | 17.08 | -35.39 | -4.72 | 5.57 | -- |
| Masimo Corp | 2.05bn | 81.50m | 7.21bn | 3.80k | 90.38 | 5.27 | 40.10 | 3.52 | 1.51 | 1.51 | 37.84 | 25.85 | 0.6552 | 2.00 | 5.04 | 538,973.70 | 2.61 | 8.65 | 3.22 | 10.31 | 49.00 | 57.30 | 3.98 | 12.03 | 1.22 | 3.43 | 0.399 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
| Inspire Medical Systems Inc | 624.80m | -21.15m | 7.38bn | 1.01k | -- | 12.58 | -- | 11.81 | -0.7298 | -0.7298 | 21.32 | 19.37 | 1.01 | 4.22 | 8.27 | 618,001.00 | -3.41 | -11.27 | -3.84 | -12.60 | 84.54 | 84.47 | -3.39 | -13.57 | 7.17 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| MSA Safety Inc | 1.79bn | 58.52m | 7.39bn | 5.10k | 131.30 | 7.68 | 61.97 | 4.14 | 1.43 | 1.43 | 45.21 | 24.59 | 0.7863 | 2.97 | 6.04 | 350,518.80 | 2.58 | 5.08 | 3.03 | 6.00 | 47.67 | 45.21 | 3.28 | 7.02 | 1.48 | 6.07 | 0.3836 | 65.91 | 17.00 | 5.65 | -67.41 | -13.66 | 4.72 | -1.10 |
| Penumbra Inc | 1.06bn | 90.95m | 7.83bn | 4.20k | 87.21 | 6.63 | 66.24 | 7.40 | 2.32 | 2.32 | 27.00 | 30.48 | 0.7232 | 1.04 | 5.23 | 252,029.00 | 6.21 | 2.32 | 6.91 | 2.61 | 64.49 | 63.90 | 8.59 | 3.17 | 3.49 | -- | 0.0215 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
| Stevanato Group SpA | 1.16bn | 156.10m | 8.28bn | 5.64k | 46.57 | 5.98 | 34.45 | 7.12 | 0.5888 | 0.5888 | 4.38 | 4.59 | 0.5818 | 3.14 | 2.75 | 206,458.70 | 7.81 | -- | 10.81 | -- | 32.28 | -- | 13.42 | -- | 1.06 | 19.74 | 0.2593 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| Henry Schein, Inc. | 12.34bn | 416.00m | 9.38bn | 25.00k | 23.17 | 2.58 | 14.00 | 0.7604 | 3.15 | 3.15 | 93.67 | 28.28 | 1.29 | 4.49 | 7.47 | 493,560.00 | 4.40 | 6.09 | 7.31 | 10.44 | 31.29 | 30.04 | 3.42 | 4.40 | 0.9963 | 10.63 | 0.3133 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
| Teleflex Inc | 2.97bn | 357.57m | 9.82bn | 14.50k | 27.58 | 2.21 | 16.37 | 3.30 | 7.56 | 7.53 | 62.88 | 94.41 | 0.4114 | 2.20 | 6.98 | 205,137.20 | 4.95 | 5.86 | 5.39 | 6.42 | 55.37 | 55.04 | 12.02 | 14.62 | 1.29 | 7.78 | 0.2901 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
Data as of Apr 30 2024. Currency figures normalised to Penumbra Inc's reporting currency: US Dollar USD
56.50%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 5.09m | 13.15% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 3.60m | 9.31% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 3.42m | 8.83% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2023 | 3.06m | 7.91% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2023 | 2.68m | 6.92% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.10m | 2.85% |
| ClearBridge Investments LLCas of 31 Dec 2023 | 800.83k | 2.07% |
| William Blair Investment Management LLCas of 31 Dec 2023 | 756.68k | 1.96% |
| FIAM LLCas of 31 Dec 2023 | 700.71k | 1.81% |
| RTW Investments LPas of 31 Dec 2023 | 662.66k | 1.71% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
